Skip to main content
. 2018 Jan 22;25(5):966–982. doi: 10.1038/s41418-017-0036-9

Fig. 3. YAP1 activation is required for TLR3-mediated neonatal cardiomyocyte proliferation.

Fig. 3

a The levels of YAP/TAZ in the myocardium are greater in P1 and P3 neonatal mice and are gradually decreased in P7, P14 and P21 neonatal mice. b, c Increased YAP levels in neonatal cardiomyocytes by transfection of AAV virus expressing activated YAP1 increased YAP1 levels (B) and promoted neonatal cardiomyocyte proliferation c. d-f Inhibition of YAP1 expression by specific siRNA for YAP1 or YAP inhibitor, verteporfin (VP) markedly suppressed Poly I:C (PIC)-induced neonatal cardiomyocyte proliferation d, YAP1 expression in cytosol e, f and nuclear translocation g. n = 3–8/group. *p < 0.05 compared with indicated groups. #p < 0.05 compared with the control group